SERPIND1

Chr 22AD

serpin family D member 1

Also known as: D22S673, HC2, HCF2, HCII, HLS2, LS2, THPH10

This gene belongs to the serpin gene superfamily. Serpins play roles in many processes including inflammation, blood clotting, and cancer metastasis. Members of this family have highly conserved secondary structures with a reactive center loop that interacts with the protease active site to inhibit protease activity. This gene encodes a plasma serine protease that functions as a thrombin and chymotrypsin inhibitor. The protein is activated by heparin, dermatan sulfate, and glycosaminoglycans. Allelic variations in this gene are associated with heparin cofactor II deficiency. [provided by RefSeq, Jul 2015]

Primary Disease Associations & Inheritance

Thrombophilia 10 due to heparin cofactor II deficiencyMIM #612356
AD
UniProtThrombophilia due to heparin cofactor 2 deficiency
525
ClinVar variants
357
Pathogenic / LP
0.00
pLI score
0
Active trials
Clinical SummarySERPIND1
🧬
Gene-Disease Validity (ClinGen)
heparin cofactor 2 deficiency · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
357 Pathogenic / Likely Pathogenic· 134 VUS of 525 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
1.50LOEUF
pLI 0.000
Z-score 0.09
OE 0.97 (0.651.50)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
-0.06Z-score
OE missense 1.01 (0.921.11)
288 obs / 285.3 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.97 (0.651.50)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.1.01 (0.921.11)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.1.11
01.21.6
LoF obs/exp: 15 / 15.4Missense obs/exp: 288 / 285.3Syn Z: -0.90

ClinVar Variant Classifications

525 submitted variants in ClinVar

Classification Summary

Pathogenic322
Likely Pathogenic35
VUS134
Likely Benign19
Benign10
Conflicting5
322
Pathogenic
35
Likely Pathogenic
134
VUS
19
Likely Benign
10
Benign
5
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
2
1
319
0
322
Likely Pathogenic
0
0
35
0
35
VUS
3
59
72
0
134
Likely Benign
0
8
2
9
19
Benign
0
3
2
5
10
Conflicting
5
Total57143014525

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

SERPIND1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

Thrombophilia 10 due to heparin cofactor II deficiency

MIM #612356

Molecular basis of disorder known

Autosomal dominant
Clinical Literature
Landmark / reviewRecent case evidence
Key Publications
Landmark & review papers · by relevance
PubMed
Proteome Characterization of Glaucoma Aqueous Humor.
Liu X et al.·Mol Cell Proteomics
2021
Top 10 resultsSearch PubMed ↗

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →